Search Results 631-640 of 17052 for pharmacogenetics
A Study to Evaluate the Effectiveness and Safety of PANZYGA in Pediatric Patients with Chronic Immune Thrombocytopenia (ITP) · Overview · Participation ...
Information will be collected on hospital readmissions, death, and decline in health from any cause following a heart attack. The goal is help older people in ...
As scientists at the Mayo Clinic Center for Individualized Medicine discover new ways to use genomic information in the diagnosis, treatment and prevention of ...
The COMMEND Study will assess the safety and effectiveness of FLX-787 in men and women with Motor Neuron Disease [including Amyotrophic Lateral Sclerosis (ALS), ...
The Ackerman Sudden Death Genomics Lab at Mayo Clinic is studying cardiac channelopathies related to long QT syndrome and catecholaminergic polymorphic ...
The objective of this study is to provide preliminary data to support the development of selected technologies for the efficient and reliable analyses of cell ...
The purpose of this study is to study both biopsy and surgical sample tissue to identify tumor-specific characteristics which may be associated with clinical ...
About this study. The short-term goal of this study is to inform the process and mechanisms to enrich URM patient accrual to interventional cancer treatment ...
Lymphoma is a diversified disease with outcomes differing upon the types and subtypes of lymphoma as well as treatment modalities used. Fertility outcomes in ...
Rochester, Minn. The purpose of this research study to compare the effects a hormone cholecystokinin (CCK) in the bloodstream in healthy people and in patients ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!